what are glp 1 receptor agonists GLP1 Agonists—Effects beyond Obesity and Diabetes GLP-1 Agonists - FAQ —
Description
GlaxoSmithKline UK Ltd
( 10.1016/j.molmet.2020.101090) [DOI] [PMC free article] [PubMed] [Google Scholar] Baggio LL, Ussher JR, McLean BA, Cao X, Kabir MG, Mulvihill EE, Mighiu AS, Zhang H, Ludwig A, Seeley RJ, et al
PKA directly phosphorylates sulfonylurea receptor 1 (SUR1), a regulatory subunit of voltage-dependent K + channels and KATP channels, increasing membrane depolarization and voltage-gated Ca 2+ channel activation
They are different treatments with different risk profiles
doi: 10.1016/S0140-6736(21)02188-7 74 BattelinoTBergenstalRMRodrguezAFernndez LandLBrayRTongZet al
